Child development following in utero exposure:levetiracetam vs sodium valproate

MLA

Shallcross, R., et al. Child Development Following in Utero Exposure:Levetiracetam vs Sodium Valproate. Jan. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ef72aa803b32e039cce35d82b745a6bb&authtype=sso&custid=ns315887.

APA

Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., Baker, G. A., Fryer, A., Kneen, R., Banka, S., Briggs, M., Clayton-Smith, J., Mawer, G., Baker, G., Bromley, R., Dixon, P., Gummery, A., Shallcross, R., Kerr, L., Craig, J., … Robertson, I. (2011). Child development following in utero exposure:levetiracetam vs sodium valproate.

Chicago

Shallcross, R, R L Bromley, B Irwin, L J Bonnett, J Morrow, G A Baker, Alan Fryer, et al. 2011. “Child Development Following in Utero Exposure:Levetiracetam vs Sodium Valproate,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ef72aa803b32e039cce35d82b745a6bb&authtype=sso&custid=ns315887.